The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Clinical impact of programmed cell death ligand 1 (PD-L1), programmed cell death 1 (PD-1), and CD8 expression in pancreatic cancer.
Hyun-Jeong Shim
No relevant relationships to disclose
Jun-Eul Hwang
No relevant relationships to disclose
Sook-In Jung
No relevant relationships to disclose
Kyung-Hwa Lee
No relevant relationships to disclose
Ik-Joo Chung
No relevant relationships to disclose
Sang-Hee Cho
No relevant relationships to disclose